Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Purpose: In patients with clinical stage IIC seminoma, residual retroperitoneal masses are detected in up to 80% of patients after chemotherapy. Lesions<3 cm are generally monitored; however, the management of patients with residuals>3 cm remains a matter of debate. Herein, we present a case series of these patients who underwent radiotherapy (RT) and discuss the role of RT in these cases.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
